印度通过实时 RT-PCR 检测对 SARS-CoV-2 进行定性检测的实验室间检测作为外部质量评估的策略。
Inter-laboratory testing as a strategy for external quality assessment for qualitative detection of SARS-CoV-2 by real-time RT-PCR testing in India.
机构信息
Virology Unit, Division of Epidemiology and Communicable Diseases, Indian Council of Medical Research, New Delhi, India.
Division of Biomedical Informatics, Indian Council of Medical Research, New Delhi, India.
出版信息
Indian J Med Res. 2022 Jan;155(1):86-90. doi: 10.4103/ijmr.ijmr_2433_21.
To implement the strategy of test, track and treat to tackle the ongoing COVID-19 pandemic, the number of real-time RT-PCR-based testing laboratories was increased for diagnosis of SARS-CoV-2 in the country. To ensure reliability of the laboratory results, the Indian Council of Medical Research initiated external quality assessment (EQA) by deploying inter-laboratory quality control (ILQC) activity for these laboratories by nominating 34 quality control (QC) laboratories. This report presents the results of this activity for a period of September 2020 till November 2020. A total of 597 laboratories participated in this activity and 86 per cent of these scored ≥90 per cent concordance with QC laboratories. This ILQC activity showcased India's preparedness in quality diagnosis of SARS-CoV-2.
为实施检测、追踪和治疗策略以应对当前的 COVID-19 大流行，我国增加了基于实时 RT-PCR 的检测实验室数量，以诊断 SARS-CoV-2。为确保实验室结果的可靠性，印度医学研究理事会通过指定 34 个质量控制（QC）实验室开展实验室间质量控制（ILQC）活动，启动了外部质量评估（EQA）。本报告介绍了 2020 年 9 月至 2020 年 11 月期间该活动的结果。共有 597 家实验室参加了该活动，其中 86%的实验室与 QC 实验室的一致性得分≥90%。该 ILQC 活动展示了印度在 SARS-CoV-2 质量诊断方面的准备情况。
Zotero 插件